Fortrea Holdings (FTRE) Asset Writedowns and Impairment (2023 - 2026)

Fortrea Holdings (FTRE) reported Asset Writedowns and Impairment of $3.0 million for Q1 2026, down 33.33% on a YoY basis from $4.5 million in Q1 2025, and down 99.62% quarter-over-quarter from $797.9 million in Q3 2025.

Fortrea Holdings (FTRE) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

Fortrea Holdings has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $3.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 33.33% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $796.4 million (up 29396.3% YoY), and the FY2025 full-year result was $797.9 million, up 3494.14% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $3.0 million, down from $797.9 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $797.9 million in Q3 2025, with the low at -$31.4 million in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged $92.9 million across 4 years, with a median of $12.2 million in 2024.
  • The largest YoY upside for Asset Writedowns and Impairment was 2641.08% in 2025 against a maximum downside of 136.89% in 2025.
  • Fortrea Holdings' Asset Writedowns and Impairment stood at $13.4 million in 2023, then increased by 29.85% to $17.4 million in 2024, then soared by 4485.63% to $797.9 million in 2025, then tumbled by 99.62% to $3.0 million in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $3.0 million (Q1 2026), $797.9 million (Q3 2025), and -$4.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Mar 31, 2026 3.00 Mn
Sep 30, 2025 797.90 Mn
Sep 30, 2025 797.90 Mn
Jun 30, 2025 -4.50 Mn
Jun 30, 2025 -4.50 Mn
Mar 31, 2025 4.50 Mn
Mar 31, 2025 4.50 Mn
Dec 31, 2024 17.40 Mn
Dec 31, 2024 17.40 Mn
Sep 30, 2024 -31.40 Mn
Sep 30, 2024 -31.40 Mn
Jun 30, 2024 12.20 Mn
Jun 30, 2024 12.20 Mn
Mar 31, 2024 24.00 Mn
Mar 31, 2024 24.00 Mn
Dec 31, 2023 13.40 Mn
Dec 31, 2023 13.40 Mn